← Back to Search

Imaging

Healthy Volunteers for Heart Failure

Q: Does this investigation accept participants who are 45 years and older?

This medical trial is welcoming patients who are older than 18 and younger than 85 years of age.

Q: Are there any eligibility criteria to become a participant in this trial?

To become part of this medical experiment, subjects must have left ventricular hypertrophy and fall between 18 to 85 years old. A total of 160 trial participants will be accepted.

Q: Are there still opportunities to be a participant in this trial?

According to the clinicaltrials.gov database, this research study is still accepting participants and was first made available on June 30th 2017 with the most recent update posted on March 1st 2022.

Q: Are there any other research projects exploring the effects of treatment in individuals with recently experienced a heart attack?

Currently, 10 studies are examining the effects of a certain treatment on Patients with Recent Myocardial Infarction. There is no Phase 3 trials as of yet. Most locations conducting these experiments can be found in Birmingham, <a href="https://www.withpower.com/clinical-trials/alabama">Alabama</a>; however, there are 26 other sites that also offer this research.

Q: Could you enlighten me as to the approximate quantity of participants in this experiment?

Affirmative. The clinical study, which was first initiated on June 30th 2017, is actively recruiting 160 patients from a single site as per the data hosted on clinicaltrials.gov that was last updated on March 1st 2022.

Q: What therapeutic advantages does Patients with Recent Myocardial Infarction offer?

Recent Myocardial Infarction sufferers can receive sialography, ercp, hysterosalpingogram and intraoperative treatments.

Phase < 1

Waitlist Available

Led By David E. Sosnovik, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is looking at using MRI to see changes in heart structure in people at risk for heart failure. Patients will have serial MRI scans to look for changes over time.

Eligible Conditions

Heart Failure
Heart Attack
Left Ventricular Hypertrophy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Myofiber Helix Angle

Secondary outcome measures

Correlation of Myofiber Helix Angle and Strain

Trial Design

3Treatment groups

Active Control

Group I: Healthy VolunteersActive Control1 Intervention

DTI will be performed in healthy volunteers to characterize normal fiber architecture in the heart and provide a comparison group for the patients imaged in the other arms.

Group II: Patients with Recent Myocardial InfarctionActive Control2 Interventions

Patients with recent ST elevation myocardial infarcts will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with remodeling of the left ventricle.

Group III: Patients with Left Ventricular HypertrophyActive Control1 Intervention

Patients with left ventricular hypertrophy and a history of heart failure will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with the onset and progression of heart failure.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,195 Total Patients Enrolled

48 Trials studying Heart Failure

209,465 Patients Enrolled for Heart Failure

David E. Sosnovik, MDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation accept participants who are 45 years and older?

"This medical trial is welcoming patients who are older than 18 and younger than 85 years of age."

Answered by AI

Are there any eligibility criteria to become a participant in this trial?

"To become part of this medical experiment, subjects must have left ventricular hypertrophy and fall between 18 to 85 years old. A total of 160 trial participants will be accepted."

Answered by AI

Are there still opportunities to be a participant in this trial?

"According to the clinicaltrials.gov database, this research study is still accepting participants and was first made available on June 30th 2017 with the most recent update posted on March 1st 2022."

Answered by AI

Are there any other research projects exploring the effects of treatment in individuals with recently experienced a heart attack?

"Currently, 10 studies are examining the effects of a certain treatment on Patients with Recent Myocardial Infarction. There is no Phase 3 trials as of yet. Most locations conducting these experiments can be found in Birmingham, Alabama; however, there are 26 other sites that also offer this research."

Answered by AI

Could you enlighten me as to the approximate quantity of participants in this experiment?

"Affirmative. The clinical study, which was first initiated on June 30th 2017, is actively recruiting 160 patients from a single site as per the data hosted on clinicaltrials.gov that was last updated on March 1st 2022."

Answered by AI